Tirzepatide
A dual GIP/GLP-1 receptor agonist — one peptide that activates two incretin pathways at once. Widely studied for weight-management and glucose-control research, often as a comparator to GLP-1 monotherapy and to triple agonists like retatrutide.
What the research has to say.
Often used for: body-composition and metabolic research, typically in 6–8 week reassessment programs.
What you get: a 3mL vial at your chosen dose plus a reconstitution kit (bacteriostatic water, alcohol swabs, syringes). HPLC-tested at ≥99% purity.
How this vial got here.
Every vial is HPLC-tested at ≥ 99% purity, lyophilized under nitrogen for stability, and shipped on cold packs when the compound requires it. Lot-traceable, with a Certificate of Analysis available on request from the wellness associate handling your order.
If you'd like to see the COA before ordering, just ask in the checkout notes — we'll send it before we ship.
A wellness associate walks you through it.
After you check out, a wellness associate emails or calls you within 24 hours. They confirm what you've ordered, walk through anything you haven't done before, and answer questions before we ship.
Often combined for fuller metabolic support.
MetabolicA small fragment of growth hormone, engineered to keep the fat-metabolism signal while dropping the broader growth effects. The C-terminal piece of hGH most tied to lipolysis.
MetabolicEli Lilly's triple agonist — a single peptide that works on three gut-hormone pathways (GLP-1, GIP, and glucagon) at once. Phase 2 trials showed up to ~24% body-weight reduction at 48 weeks at higher doses, with improvements in glucose control and liver fat.
MetabolicAn "exercise-mimetic" compound developed at Saint Louis University. Activates the metabolic gene programs your cells use during endurance training — fat-oxidation, mitochondrial biogenesis, oxidative metabolism.